PharVision Advisers »

Iradimed shares owned by PharVision Advisers

Quarter-by-quarter ownership of Iradimed (IRMD) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Iradimed

Tip: Access up to 7 years of quarterly data

All positions including Iradimed held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iradimed by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $257k 3.6k 71.16

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Iradimed

BlackRock
Nine Ten Capital Management
Vanguard Group
Renaissance Technologies
Copeland Capital Management
Geode Capital Management
Dimensional Fund Advisors
State Street Corporation
Goldman Sachs Group
Acadian Asset Management
Northern Trust
Ranger Investment Management
Russell Investments
Bank of New York Mellon
Millennium Management

View all funds holding Iradimed